Diabetes mellitus drug discovery: insights into targeting feline and human amylin with small molecules

References

• Azam F, Prasad MV, Thangavel N, Shrivastava AK, Mohan G. 2012. Structure-based design, synthesis and molecular modeling studies of thiazolyl urea derivatives as novel anti-parkinsonian agents. Med Chem. 8(6):1057–1068. doi: 10.2174/1573406411208061057.
   PubMed Web of Science ®Google Scholar
• Betsholtz C, Christmanson L, Engström U, Rorsman F, Jordan K, O’Brien TD, Murtaugh M, Johnson KH, Westermark P. 1990. Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes. 39(1):118–122. doi: 10.2337/diacare.39.1.118.
   PubMed Web of Science ®Google Scholar
• Betsholtz C, Christmansson L, Engström U, Rorsman F, Svensson V, Johnson KH, Westermark P. 1989. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 251(1-2):261–264. doi: 10.1016/0014-5793(89)81467-x.
   PubMed Web of Science ®Google Scholar
• Bhagat V, Verchere CB. 2023. A small molecule improves diabetes in mice expressing human islet amyloid polypeptide. Islets. 15(1):12–15. doi: 10.1080/19382014.2022.2163829.
   PubMed Web of Science ®Google Scholar
• Bloem BR, Okun MS, Klein C. 2021. Parkinson’s disease. Lancet. 397(10291):2284–2303. doi: 10.1016/S0140-6736(21)00218-X.
   PubMed Web of Science ®Google Scholar
• Busche MA, Hyman BT. 2020. Synergy between amyloid-beta and tau in Alzheimer’s disease. Nat Neurosci. 23(10):1183–1193. doi: 10.1038/s41593-020-0687-6.
   PubMed Web of Science ®Google Scholar
• Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC. 2004. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes. 53(6):1509–1516. doi: 10.2337/diabetes.53.6.1509.
   PubMed Web of Science ®Google Scholar
• Buxbaum JN, Dispenzieri A, Eisenberg DS, Fändrich M, Merlini G, Saraiva MJM, Sekijima Y, Westermark P. 2022. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 29(4):213–219. doi: 10.1080/13506129.2022.2147636.
   PubMed Web of Science ®Google Scholar
• Cao Q, Boyer DR, Sawaya MR, Ge P, Eisenberg DS. 2020. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils. Nat Struct Mol Biol. 27(7):653–659. doi: 10.1038/s41594-020-0435-3.
   PubMed Web of Science ®Google Scholar
• Choi BC, Shi F. 2001. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey. Diabetologia. 44(10):1221–1231. doi: 10.1007/s001250100648.
   PubMed Web of Science ®Google Scholar
• Cox SJ, Rodriguez Camargo DC, Lee Y-H, Dubini RCA, Rovó P, Ivanova MI, Padmini V, Reif B, Ramamoorthy A. 2020. Small molecule induced toxic human-IAPP species characterized by NMR. Chem Commun. 56(86):13129–13132. doi: 10.1039/d0cc04803h.
   PubMed Web of Science ®Google Scholar
• Elkamhawy A, Park J-E, Hassan AHE, Ra H, Pae AN, Lee J, Park B-G, Moon B, Park H-M, Roh EJ, et al. 2017. Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: a new modulator for amyloid beta-induced mitochondrial dysfunction. Eur J Med Chem. 128:56–69. doi: 10.1016/j.ejmech.2016.12.057.
   PubMed Web of Science ®Google Scholar
• Fortin JS, Benoit-Biancamano M-O, C-Gaudreault R. 2016. Discovery of ethyl urea derivatives as inhibitors of islet amyloid polypeptide fibrillization and cytotoxicity. Can J Physiol Pharmacol. 94(3):341–346. doi: 10.1139/cjpp-2015-0204.
   PubMed Web of Science ®Google Scholar
• Galamba N. 2022. Aggregation of a Parkinson’s disease-related peptide: when does urea weaken hydrophobic interactions? ACS Chem Neurosci. 13(12):1769–1781. doi: 10.1021/acschemneuro.2c00169.
   PubMed Web of Science ®Google Scholar
• García-Viñuales S, Ilie IM, Santoro AM, Romanucci V, Zarrelli A, Di Fabio G, Caflisch A, Milardi D. 2022. Silybins inhibit human IAPP amyloid growth and toxicity through stereospecific interactions. Biochim Biophys Acta Proteins Proteom. 1870(5):140772. doi: 10.1016/j.bbapap.2022.140772.
   PubMed Web of Science ®Google Scholar
• Guardado-Mendoza R, Davalli AM, Chavez AO, Hubbard GB, Dick EJ, Majluf-Cruz A, Tene-Perez CE, Goldschmidt L, Hart J, Perego C, et al. 2009. Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci U S A. 106(33):13992–13997. doi: 10.1073/pnas.0906471106.
   PubMed Web of Science ®Google Scholar
• Gut WN. 2019. Efficacy and mechanism of action of long-term treatment with antibody NI-203.26C11 targeting aggregated IAPP in type 2 diabetes. University of Zurich. doi: 10.5167/uzh-175725.
   Google Scholar
• Haataja L, Gurlo T, Huang CJ, Butler PC. 2008. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev. 29(3):303–316. doi: 10.1210/er.2007-0037.
   PubMed Web of Science ®Google Scholar
• Hull RL, Westermark GT, Westermark P, Kahn SE. 2004. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab. 89(8):3629–3643. doi: 10.1210/jc.2004-0405.
   PubMed Web of Science ®Google Scholar
• Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE. 2018. A new era for understanding amyloid structures and disease. Nat Rev Mol Cell Biol. 19(12):755–773. doi: 10.1038/s41580-018-0060-8.
   PubMed Web of Science ®Google Scholar
• Kim JR, Muresan A, Lee KY, Murphy RM. 2004. Urea modulation of beta-amyloid fibril growth: experimental studies and kinetic models. Protein Sci. 13(11):2888–2898. doi: 10.1110/ps.04847404.
   PubMed Web of Science ®Google Scholar
• King KM, Bevan DR, Brown AM. 2022. Molecular dynamics simulations indicate aromaticity as a key factor in the inhibition of IAPP((20-29)) aggregation. ACS Chem Neurosci. 13(11):1615–1626. doi: 10.1021/acschemneuro.2c00025.
   PubMedGoogle Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46(1-3):3–26. doi: 10.1016/s0169-409x(00)00129-0.
   PubMed Web of Science ®Google Scholar
• Lorenzo A, Razzaboni B, Weir GC, Yankner BA. 1994. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368(6473):756–760. doi: 10.1038/368756a0.
   PubMed Web of Science ®Google Scholar
• Lutz TA. 2010. The role of amylin in the control of energy homeostasis. Am J Physiol Regul Integr Comp Physiol. 298(6):R1475–84. doi: 10.1152/ajpregu.00703.2009.
   PubMed Web of Science ®Google Scholar
• Maity D. 2023. Recent advances in the modulation of amyloid protein aggregation using the supramolecular host-guest approaches. Biophys Chem. 297:107022. doi: 10.1016/j.bpc.2023.107022.
   PubMed Web of Science ®Google Scholar
• Mannam MR, Devine SR, Pavuluri CM, Chamarthi NR, Kottapalli RSP. 2019. Urea and thiourea derivatives of 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1, 2, 4]triazolo[4,3-a]pyrazine: synthesis, characterization, antimicrobial activity and docking studies. Phosphorus Sulfur Silicon Relat Elem. 194(9):922–932. doi: 10.1080/10426507.2019.1577845.
   Web of Science ®Google Scholar
• Martinez Pomier K, Ahmed R, Melacini G. 2022. Interactions of intrinsically disordered proteins with the unconventional chaperone human serum albumin: from mechanisms of amyloid inhibition to therapeutic opportunities. Biophys Chem. 282:106743. doi: 10.1016/j.bpc.2021.106743.
   PubMed Web of Science ®Google Scholar
• McCann TM, Simpson KE, Shaw DJ, Butt JA, Gunn-Moore DA. 2007. Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J Feline Med Surg. 9(4):289–299. doi: 10.1016/j.jfms.2007.02.001.
   PubMed Web of Science ®Google Scholar
• Meleleo D, Gerbino A, Mastrodonato M. 2022. Evidence of the different effect of mercury and cadmium on the hIAPP aggregation process. Biophys Chem. 290:106880. doi: 10.1016/j.bpc.2022.106880.
   PubMed Web of Science ®Google Scholar
• Milardi D, Gazit E, Radford SE, Xu Y, Gallardo RU, Caflisch A, Westermark GT, Westermark P, Rosa CL, Ramamoorthy A, et al. 2021. Proteostasis of islet amyloid polypeptide: a molecular perspective of risk factors and protective strategies for type II diabetes. Chem Rev. 121(3):1845–1893. doi: 10.1021/acs.chemrev.0c00981.
   PubMed Web of Science ®Google Scholar
• Mounetou E, Miot-Noirault E, Gaudreault RC, Madelmont JC. 2010. N-4-iodophenyl-N’-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profiles. Invest New Drugs. 28(2):124–131. doi: 10.1007/s10637-009-9222-z.
   PubMed Web of Science ®Google Scholar
• Muchtar E, Dispenzieri A, Magen H, Grogan M, Mauermann M, McPhail ED, Kurtin PJ, Leung N, Buadi FK, Dingli D, et al. 2021. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 289(3):268–292. doi: 10.1111/joim.13169.
   PubMed Web of Science ®Google Scholar
• O’Brien TD. 2002. Pathogenesis of feline diabetes mellitus. Mol Cell Endocrinol. 197(1-2):213–219. doi: 10.1016/s0303-7207(02)00265-4.
   PubMed Web of Science ®Google Scholar
• O’Neill DG, Gostelow R, Orme C, Church DB, Niessen SJM, Verheyen K, Brodbelt DC. 2016. Epidemiology of diabetes mellitus among 193,435 cats attending primary-care veterinary practices in England. J Vet Intern Med. 30(4):964–972. doi: 10.1111/jvim.14365.
   PubMed Web of Science ®Google Scholar
• Patel AG, Toyama MT, Alvarez C, Nguyen TN, Reber PU, Ashley SW, Reber HA. 1995. Pancreatic interstitial pH in human and feline chronic pancreatitis. Gastroenterology. 109(5):1639–1645. doi: 10.1016/0016-5085(95)90654-1.
   PubMed Web of Science ®Google Scholar
• Petitclerc E, Deschesnes RG, Côté M-F, Marquis C, Janvier R, Lacroix J, Miot-Noirault E, Legault J, Mounetou E, Madelmont J-C, et al. 2004. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance. Cancer Res. 64(13):4654–4663. doi: 10.1158/0008-5472.CAN-03-3715.
   PubMed Web of Science ®Google Scholar
• Pithadia A, Brender JR, Fierke CA, Ramamoorthy A. 2016. Inhibition of IAPP aggregation and toxicity by natural products and derivatives. J Diabetes Res. 2016:2046327–2046312. doi: 10.1155/2016/2046327.
   PubMed Web of Science ®Google Scholar
• Prahl A, Guptill L, Glickman NW, Tetrick M, Glickman LT. 2007. Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. J Feline Med Surg. 9(5):351–358. doi: 10.1016/j.jfms.2007.02.004.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan P, Bryant VC, Blowers EC, Rajule RN, Gautam N, Anwar MM, Mohr AM, Grandgenett PM, Bunt SK, Arnst JL, et al. 2013. Targeting the NF-kappaB and mTOR pathways with a quinoxaline urea analog that inhibits IKKbeta for pancreas cancer therapy. Clin Cancer Res. 19(8):2025–2035. doi: 10.1158/1078-0432.CCR-12-2909.
   PubMed Web of Science ®Google Scholar
• Rand JS. 2013. Pathogenesis of feline diabetes. Vet Clin North Am Small Anim Pract. 43(2):221–231. doi: 10.1016/j.cvsm.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Rodriguez Camargo DC, Garg D, Buday K, Franko A, Rodriguez Camargo A, Schmidt F, Cox SJ, Suladze S, Haslbeck M, Mideksa YG, et al. 2018. hIAPP forms toxic oligomers in plasma. Chem Commun. 54(43):5426–5429. doi: 10.1039/c8cc03097a.
   PubMed Web of Science ®Google Scholar
• Sevcuka A, White K, Terry C. 2022. Factors that contribute to hIAPP amyloidosis in type 2 diabetes mellitus. Life. 12(4):583. doi: 10.3390/life12040583.
   PubMedGoogle Scholar
• Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. 2022. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 183:109119. doi: 10.1016/j.diabres.2021.109119.
   PubMed Web of Science ®Google Scholar
• Wang L, Colon W. 2005. Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer. Protein Sci. 14(7):1811–1817. doi: 10.1110/ps.051387005.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu T, Wei J, Yin X, Gao Z, Li H. 2022. Inhibitory activities of flavonoids from Scutellaria baicalensis Georgi on amyloid aggregation related to type 2 diabetes and the possible structural requirements for polyphenol in inhibiting the nucleation phase of hIAPP aggregation. Int J Biol Macromol. 215:531–540. doi: 10.1016/j.ijbiomac.2022.06.107.
   PubMed Web of Science ®Google Scholar
• Westermark GT, Falkmer S, Steiner DF, Chan SJ, Engstrom U, Westermark P. 2002. Islet amyloid polypeptide is expressed in the pancreatic islet parenchyma of the teleostean fish, Myoxocephalus (cottus) scorpius. Comp Biochem Physiol B Biochem Mol Biol. 133(1):119–125. doi: 10.1016/s1096-4959(02)00113-6.
   PubMed Web of Science ®Google Scholar
• Westermark P, Andersson A, Westermark GT. 2011. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 91(3):795–826. doi: 10.1152/physrev.00042.2009.
   PubMed Web of Science ®Google Scholar
• Zhang M, Ren B, Liu Y, Liang G, Sun Y, Xu L, Zheng J. 2017. Membrane interactions of hIAPP monomer and oligomer with lipid membranes by molecular dynamics simulations. ACS Chem Neurosci. 8(8):1789–1800. doi: 10.1021/acschemneuro.7b00160.
   PubMed Web of Science ®Google Scholar